Unimed Dorzolamide

Unimed Dorzolamide





Concise Prescribing Info
Dorzolamide HCl
Elevated IOP in patients w/ ocular HTN, open-angle glaucoma.
Dosage/Direction for Use
Monotherapy Instill 1 drop tds in conjuctival sac of affected eye(s). Adjunctive therapy w/ ophth β-blocker Instill 1 drop bd in conjunctival sac of affected eye(s). When substituting for another ophth antiglaucoma agent Discontinue other agent after dosing on 1 day & start dorzolamide the next day.
Special Precautions
Hypersensitivity to sulphonamides. Discontinue use if allergic reactions eg, conjunctivitis & eyelid reactions occur. Acute angle-closure glaucoma; history of renal calculi; preexisting chronic corneal defects &/or history of intraocular surgery. Patients w/ significant renal tubular immaturity. Eye irritation due to benzalkonium Cl. Not recommended in concomitant use w/ carbonic anhydrase inhibitors. Remove contact lens prior to application & wait at least 15 min before reinsertion. Administer at least 10 min apart if >1 topical ophth drug is being used. Hepatic impairment. Pregnancy & lactation. Patients <36 wk gestational age & infants <1 wk.
Adverse Reactions
Burning, stinging. Headache; superficial punctate keratitis, tearing, conjunctivitis, eyelid inflammation & irritation, eye itching, blurred vision; nausea, bitter taste; asthenia, fatigue.
ATC Classification
S01EC03 - dorzolamide ; Belongs to the class of carbonic anhydrase inhibitors. Used in the treatment of glaucoma.
Unimed Dorzolamide eye drops 2% w/v
5 mL x 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in